Alira Health is pleased to announce that David Uffer has joined the firm as a Partner, bringing his extensive expertise in business strategy, transaction services, and strategy execution to Alira Health’s clients worldwide.
“As a former Alira Health client, I was impressed with the incredible talent on their team and the firm’s holistic and innovative approach to global healthcare advisory services,” said Uffer. “I am excited to help Alira Health further develop their capabilities across multiple healthcare sectors.”
Uffer comes to Alira Health with over 20 years of management experience in medical device, products and clinical diagnostics. His broad expertise includes diverse segments such as respiratory and critical care medicine, urology/gynecology and breast health, minimally invasive surgery, oncology, interventional medicine, and in vitro and molecular diagnostics. He has led strategy development, strategic planning and business development activities in these fields for mid and large cap public companies.
Uffer has directed business development deals ranging from M&A, licensing, distribution and co-development for companies such as Medtronic (legacy Covidien), Hologic and Boston Scientific. He has demonstrated leadership driving growth objectives while in management roles at Integra Lifesciences and Abbott Labs.
“David is well-respected and accomplished in the healthcare space,” said Gabriele Brambilla, CEO of Alira Health. "He has led multi-billion dollar acquisitions and developed successful transformational strategies at his previous companies. He understands the internal operations and challenges of healthcare companies and will use his experience to help our clients assess risk, maximize value, and grow their businesses."